These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20925998)

  • 21. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients.
    Hayashi K; Ina H; Tezuka M; Okada Y; Irie T
    Cardiovasc Intervent Radiol; 2007; 30(6):1144-55. PubMed ID: 17909884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.
    Matsuo N; Uchida H; Nishimine K; Soda S; Oshima M; Nakano H; Nagano N; Nishimura Y; Yoshioka T; Guo Q
    J Vasc Interv Radiol; 1993; 4(4):543-9. PubMed ID: 8394758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectral CT-Based Iodized Oil Quantification to Predict Tumor Response Following Chemoembolization of Hepatocellular Carcinoma.
    Choi WS; Chang W; Lee M; Hur S; Kim HC; Jae HJ; Chung JW; Choi JW
    J Vasc Interv Radiol; 2021 Jan; 32(1):16-22. PubMed ID: 33162309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute respiratory distress syndrome after transcatheter arterial chemoembolization of hepatocellular carcinomas.
    Wu GC; Perng WC; Chen CW; Chian CF; Peng CK; Su WL
    Am J Med Sci; 2009 Nov; 338(5):357-60. PubMed ID: 19826242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CT evaluation of transcatheter arterial chemo-embolization, using iodized oil for hepatocellular carcinoma.
    Isaza MO; Kuroda C; Marukawa T; Tokunaga K; Hosoki T; Masuike M; Monden M; Sakurai M; Kozuka T
    Med J Osaka Univ; 1990 Mar; 39(1-4):23-32. PubMed ID: 1369648
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization.
    Koh YH; Choi JI; Kim HB; Kim MJ
    Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter arterial chemotherapy using doxorubicin, iodized oil and Gelfoam embolization in hepatocellular carcinoma.
    Van Beers B; Roche A; Cauquil P; Jamart J; Pariente D; Ajavon Y
    Acta Radiol; 1989; 30(4):415-8. PubMed ID: 2550043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein.
    Lee JH; Won JH; Park SI; Won JY; Lee DY; Kang BC
    J Vasc Interv Radiol; 2007 Mar; 18(3):377-82. PubMed ID: 17377183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma.
    Won JY; Lee DY; Lee JT; Park SI; Kim MJ; Yoo HS; Suh SH; Park SJ
    Cardiovasc Intervent Radiol; 2003; 26(2):136-40. PubMed ID: 12638036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
    Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
    Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization.
    Miyayama S; Matsui O; Taki K; Minami T; Ryu Y; Ito C; Nakamura K; Inoue D; Notsumata K; Toya D; Tanaka N; Mitsui T
    Cardiovasc Intervent Radiol; 2006; 29(1):39-48. PubMed ID: 16328697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.
    Minami Y; Kudo M; Kawasaki T; Kitano M; Chung H; Maekawa K; Shiozaki H
    AJR Am J Roentgenol; 2003 Mar; 180(3):703-8. PubMed ID: 12591679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
    Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
    Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma.
    Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M
    AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography.
    Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Matsui O
    Cardiovasc Intervent Radiol; 2009 Mar; 32(2):255-64. PubMed ID: 19067043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Yoshimatsu R; Yamagami T; Ishikawa M; Kajiwara K; Aikata H; Chayama K; Awai K
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):865-74. PubMed ID: 26711803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.